Drug recall
Microgestin Fe 1/20 (Norethindrone Acetate and Ethinyl Estradiol Tablets, USP and Ferrous Fumarate Tablets)…
FDA recall event 28511 · Class III · Watson Pharmaceuticals Inc
Key facts
| Event ID | 28511 |
|---|---|
| Recall numbers | D-131-4 |
| Recalling firm | Watson Pharmaceuticals Inc |
| Product type | Drugs |
| Products | Microgestin Fe 1/20 (Norethindrone Acetate and Ethinyl Estradiol Tablets, USP and Ferrous Fumarate Tablets), 28-Day Regimen, Each white tablet (21) contains 1 mg norethindrone acetate and 20 mcg… |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Subpotent; ethinyl estradiol component (18 month stability) |
| Initiation date | Mar 3, 2004 |
| Termination date | Dec 14, 2007 |
| City | Corona |
| State | CA |
| Country | United States |
| FEI number | 3003944123 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports